INP104
Impel Pharmaceuticals
[' aa ', ' rev ']
today at #aanam we re presenting an analysis in a small population from our pivotal stop 301 study in acute #migraine that found no significant safety concerns emerged from off-protocol, concomitant use of triptans and trudhesa. abstract: 
Developing life-changing, innovative therapies for diseases with unmet needs